Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Ophthalmology. 2012 Dec 1;120(3):451–456. doi: 10.1016/j.ophtha.2012.09.007

Table 3.

Study period herpes zoster ophthalmicus incidence by presentation, age, and gender (January 1, 2006 to December 31, 2007)

Age(years) Female Male All Cases
All Presentations N Rate (95%CI)1 N Rate (95% CI)1 N Rate (95% CI)1
 Total 71 32.4 (25.3–40.9) 63 29.3 (22.5–37.5) 134 30.9 (25.9–36.6)

  014 1 2.6 (0.1–14.3) 1 2.4 (0.1–13.6) 2 2.5 (0.3–9.0)
  1524 1 3.6 (0.1–20.3) 3 10.6 (2.2–31.0) 4 7.2 (2.0–18.4)
  2544 9 15.4 (7.0–29.2) 9 15.5 (7.1–29.4) 18 15.4 (9.1–24.4)
  4564 29 45.0 (30.1–64.6) 25 39.4 (25.5–58.2) 54 42.2 (31.7–55.1)
  ≥65 31 104.9 (71.3–148.9) 25 104.2 (67.5–153.9) 56 104.6 (79.0–135.9)

Specific Presentations2

 Blepharitis 1 0.5 (0.0–2.5) - 0.0 (0.0–1.7) 1 0.2 (0.0–1.3)
 Conjunctivitis 19 8.7 (5.2–13.5) 13 6.1 (3.2–10.4) 32 7.4 (5.0–10.4)
 Dermatitis 53 24.2 (18.1–31.7) 50 23.3 (17.3–30.7) 103 23.7 (19.4–28.8)
 Keratitis 20 9.1 (5.6–14.1) 18 8.4 (5.0–13.2) 38 8.8 (6.2–12.0)
 Uveitis 3 1.4 (0.3–4.0) 5 2.3 (0.8–5.4) 8 1.8 (0.8–3.6)
1

Incidence rates are reported per 100,000 person-years. Range in parentheses indicates 95% confidence interval (CI).

2

Patients were counted more than once if presenting with more than one manifestation of herpes zoster ophthalmicus.